ALK GENE MUTATION
Clinical trials for ALK GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new ALK GENE MUTATION trials appear
Sign up with your email to follow new studies for ALK GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy trial aims to stall aggressive lung cancer
Disease control OngoingThis study is testing if a targeted drug called brigatinib works better alone or when combined with two chemotherapy drugs for people with advanced lung cancer that has a specific genetic change (ALK-positive). About 110 patients who haven't had treatment for their advanced cance…
Matched conditions: ALK GENE MUTATION
Phase: PHASE2 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Smartphones and fitbits track cancer drug side effects in real-time
Knowledge-focused OngoingThis study is testing a remote monitoring system to better track symptoms and side effects in lung cancer patients taking oral targeted therapy pills. Participants use a smartphone app, a Fitbit watch, and a smart pill bottle cap for up to 24 weeks. The goal is to see if this sys…
Matched conditions: ALK GENE MUTATION
Phase: NA • Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:56 UTC